Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Cameco Corporation is a Canadian energy company focused on providing uranium and nuclear fuel products for electricity generation across the Americas, Europe, and Asia. The company operates through three main segments: Uranium, Fuel Services, and Westinghouse. Its Uranium segment is responsible for the exploration, mining, milling, purchase, and sale of uranium concentrate used as a primary input for nuclear power plants. The Fuel Services segment refines, converts, and fabricates uranium concentrate into fuel forms, and also manages the purchase and sale of conversion services for utilities. Through the Westinghouse segment, Cameco acts as a nuclear reactor technology original equipment manufacturer, supplying products, engineering support, outage and maintenance services, and critical components to commercial utilities and government agencies. Cameco’s customer base consists mainly of nuclear utilities that rely on secure, long-term supply of uranium and fuel services to support baseload, low-carbon electricity generation. Incorporated in 1987 and headquartered in Saskatoon, Canada, Cameco Corporation plays a central role in the global nuclear fuel supply chain.
$97.39
+$3.77 (+4.03%)
Live · 11:52 PM
17.84% operating margin is respectable but not wide. ROIC at 6.97%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 51.2%, still solid.
At 91x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
91.1x earnings, 64.5x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
C$3.54B
▲ +51.2% YoY
Net Income (TTM)
C$651M
▲ +367.2% YoY
Op. Margin
17.44%
▲ +1.5pp YoY
ROIC
6.97%
▲ +3.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
C$922M
▲ +111.1% YoY
Op. Cash Flow (TTM)
C$1.90B
▲ +64.6% YoY
Net Debt
-C$218M
Net Cash Position
Cash & Equiv.
C$1.21B
3Y CAGR: +23.1%
3Y CAGR: +88.3%
Continue Research
At a P/E of 91.1 and a price-to-free-cash-flow of 64.5, Cameco (CCJ) trades around a two-stage DCF intrinsic value of about C$107.30 per share, so at C$97.39 the stock looks around fair value (10.2% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Cameco scores 75/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 0.2%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about C$107.30 per share for CCJ, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around C$80.47. At today's C$97.39, that puts the stock about 10.2% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Cameco scores 75 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 17.4% operating margin and a 7.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Cameco pays a regular dividend of about C$0.24 per share per year (typically in quarterly installments), a yield of roughly 0.2% at the current price. That is a payout ratio of about 16.1% of earnings, so the dividend is amply covered by earnings. Cameco has grown the dividend at roughly 34.6% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For CCJ's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. CCJ currently trades around its estimated intrinsic value and scores 75/100 on quality (solid). It also yields about 0.2%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.